Filing Flows › Fuel Tech (FTEK) › Guidance & outlook

Fuel Tech (FTEK) guidance and outlook

Fuel Tech's 10-Q filed Nov 3, 2026 makes 7 forward-looking statements.

Guidance and outlook

7 statements; tone +0.14 (−1 all cautious, +1 all confident); 0 hedged.

Forward-looking statements, 10-Q filed Nov 3, 2026

The FUEL CHEM segment benefited from improved demand from legacy customers, while Air Pollution Control segment revenue increased as the Company advanced existing projects and continued to pursue and secure new contract awards.
The Company is also investing in new technologies intended to broaden its addressable market, including potential applications in the water and wastewater treatment market.
The Company believes its existing capital resources are sufficient to support current operations, planned technology development, and reasonably anticipated operating requirements.
The Company continues to execute on existing Air Pollution Control projects while pursuing and booking new contract awards.
Our current backlog consists of U.S. domestic delivered projects totaling $ 14,403 and international delivered projects totaling $ 2,223 .
We expect to continue operating under this arrangement for the foreseeable future.
We believe our current cash position and net cash flows expected to be generated from operations are adequate to fund planned operations of the Company for the next 12 months.

Fuel Tech's latest quarter

Fuel Tech, Q3 2026: revenue $8.7M (+16% year over year), operating margin -6.0%, net loss $267K, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.

Questions

What does Fuel Tech expect?

The FUEL CHEM segment benefited from improved demand from legacy customers, while Air Pollution Control segment revenue increased as the Company advanced existing projects and continued to pursue and secure new contract awards. The Company is also investing in new technologies intended to broaden its addressable market, including potential applications in the water and wastewater treatment market. The Company believes its existing capital resources are sufficient to support current operations, planned technology development, and reasonably anticipated operating requirements.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.